Approval · Notice of Compliance 8003 · 2006
ZIMOR: Notice of Compliance 8003
Issued June 1, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8003
- Date
- June 1, 2006
- Company
- Les Laboratoires NovichemBrossard, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Lipid metabolism regulator
- Canadian reference product
- ZOCOR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZIMOR | 02280493 | — |
| ZIMOR | 02280507 | — |
Medicinal ingredients
- SIMVASTATIN 20 MG per TAB
- SIMVASTATIN 40 MG per TAB